News
Pinnacle Financial Partners, Inc. (Nasdaq/NGS: PNFP) today announced it will release its second quarter 2025 financial results on Tuesday, July 15, 2025, after market close. It will also host a live ...
Blue Earth Therapeutics today announced radiation dosimetry results for its radiohybrid lutetium labelled, PSMA targeted, ...
Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4% ...
The Fiera Capital Small Cap Growth SMA returned -8.88% (net of fees), outperforming its benchmark for Q1 2025. Click here to ...
11h
ADWEEK on MSNHow Paris Saint-Germain Fans Will Make NFL and NBA Games BetterParis Saint-Germain and CrowdIQ are sharing stadium atmosphere data with the NBA's San Antonio Spurs and NFL's Tennessee ...
Work is already underway to reduce the tax-funded subsidies supporting city operations intended to be self-funded.
We favor dividend growth over high yield, spotlighting 3 undervalued, fast-growing, investment-grade stocks with 10–16% ...
Big investors are preparing for the normally thinly-traded months ahead with even more caution than usual as risks of oil ...
The conflict is affecting around 90,000 Missourians with University of Missouri Health Care providers and Anthem insurance ...
The promises are enticing: stock market upside with no risk on the downside. Or market“ participation” with downside“ ...
Overall age-adjusted mortality rates have fallen, but the poorest parts of the world aren’t sharing in the benefits.
Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results